Search   Register   Login
Search Pink Ribbon News

with all of the words
without the words
Search Results
Pages 1 2 3 4 5
2014/02/18 Study finds more women receiving breast reconstruction after mastectomy
A new study finds that the majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, a practice that has increased dramatically over time. Researchers found that 46 percent of patients received reconstruction in 1998 but that figure rose to 63 percent by 2007.

2014/02/17 Published study validates MammaPrint test for long-term prediction of breast cancer outcome
A newly published study concludes that the MammaPrint® breast cancer test can accurately stratify a woman's breast cancer risk for up to 25 years after she is first diagnosed with the disease. U.S. and Dutch researchers reported the longest-term follow-up study of its kind that confirms the dur

2014/02/16 Targeting stem cells in triple-negative breast cancer
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple nega

2014/02/15 Predicting presence of breast cancer through small non-coding RNAs
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO Reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to disting

2014/02/14 New study reinforces major advantages of Dako's HER2 IQFISH pharmDx in breast cancer diagnostics
Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, have announced positive findings in an independent French multicenter study on the performance of Dako's HER2 IQFISH pharmDx(TM). The Toulouse, France, breast cancer group led by Magali Lacroix-Triki has published

2014/02/13 Screening a library of FDA-approved anticancer drugs may lead to treatment of rare, drug-resistant cancer
University of Pittsburgh Cancer Institute (UPCI) scientists have shown that old drugs might be able to do new tricks. By screening a library of FDA-approved anticancer drugs that previously wouldn't have been considered as a treatment for a rare type of cancer, UPCI scientists were surprised when

2014/02/12 Screening mammography saves lives - Canadian study 'not relevant to Australia'
The weight of scientific evidence shows mammographic screening for breast cancer is a lifesaving public health intervention irrespective of a new Canadian study that questions mortality benefit, Cancer Council Australia said today (13 Feb). Cancer Council Australia CEO, Professor Ian Olver, said th

2014/02/11 How dense breast tissue drives the early stages of cancer
Scientists from The University of Manchester working with IBM Research have identified a key biological mechanism that for the first time explains why women with dense breast tissue are at greater risk of developing breast cancer. The research, published in the journal Cell Cycle, has important im

2014/02/10 New breast cancer treatment Kadcyla given green light by regulators, UK
Kadcyla is now available for patients with advanced HER2-positive breast cancer. Kadcyla is the first medicine of its kind in breast cancer, consisting of the HER2-targeted antibody, trastuzumab (contained in the medicine Herceptin), linked with the chemotherapy agent, DM1. In response to the pivota

2014/02/09 Bladder cancer subtypes genetically similar to breast cancer subtypes
Researchers at the UNC School of Medicine conducted a comprehensive genetic analysis of invasive bladder cancer tumors to discover that the disease shares genetic similarities with two forms of breast cancer. The finding is significant because a greater understanding of the genetic basis of cancers,

Pages 1 2 3 4 5 Found:48


Copyright 1997-2011 Pink Ribbon Inc. / Pink Ribbon International   Terms and Conditions  Privacy Policy